MANKIND PHARMA
Back to Income Statement
|
MANKIND PHARMA Last 5 Year Profit After Tax History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit After Tax | ₹1,941 Cr | ₹130,968 Cr | ₹1,453 Cr | ₹129 Cr | ₹10,561 Cr |
What is the latest Profit After Tax of MANKIND PHARMA ?
| Year | Profit After Tax |
|---|---|
| Mar2025 | ₹1,941 Cr |
| Mar2024 | ₹130,968 Cr |
| Mar2023 | ₹1,453 Cr |
| Mar2022 | ₹129 Cr |
| Mar2021 | ₹10,561 Cr |
How is Profit After Tax of MANKIND PHARMA Trending?
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,941 Cr | -98.52 | |
| Mar2024 | ₹130,968 Cr | 8,913.86 | |
| Mar2023 | ₹1,453 Cr | 1,023.68 | |
| Mar2022 | ₹129 Cr | -98.78 | |
| Mar2021 | ₹10,561 Cr | - | |
Compare Profit After Tax of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹92,737.6 Cr | -0.9% | 10.1% | -11.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,848.0 Cr | 11.6% | 0.7% | -0.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,697.0 Cr | 2.3% | 8.5% | 8.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,859.0 Cr | 1.8% | -1.8% | 30.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,421.0 Cr | 0.5% | 3.2% | 13.3% | Stock Analytics | |
| CIPLA | ₹105,811.0 Cr | 1.2% | 5.4% | -13.7% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | -0.9% |
10.1% |
-11.6% |
| SENSEX | -1% |
2.2% |
-3.6% |
You may also like the below Video Courses